Endo International plc
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $2.01B | $2.32B | $2.99B | $2.90B | $2.91B | $2.95B |
| Operating income | — | — | — | — | — | −$469.1M |
| Net income | −$2.45B | −$2.92B | −$613.2M | $183.9M | −$422.6M | −$1.03B |
| Total assets | $5.14B | $5.76B | $8.77B | $9.26B | $9.39B | $10.13B |
| Total liabilities | — | — | — | — | — | — |
| Equity | −$6.60B | −$4.16B | −$1.24B | −$647.9M | −$866.5M | −$498.3M |
| EPS (diluted) | $-10.42 | $-12.45 | $-2.63 | $0.79 | $-1.87 | $-4.61 |
| Shares out. | 235.2M | 233.7M | 230.5M | 226.8M | 224.4M | 223.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- —
- Net margin
- −121.8%
- Return on equity
- 37.1%
- Return on assets
- −47.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $-28.05
- Revenue growth (YoY)
- −13.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Accruals / assets
- −56.2%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 2 warning● 3 good- Negative shareholder equity
- Reported a net loss
- Revenue declined year-over-year
- Strong return on equity (>15%)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Oaktree Capital Group Holdings Gp, LlcPassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Tursi James PatrickOfficer — Executive VP, Global R&D | Jul 15, 2022 | D | 280,373 | — |
| Barry Patrick AOfficer — EVP & Pres,Global Comm Ops | Mar 29, 2022 | Tax withholding | 4,141 | $2.52 |
| Raciti Frank B.Officer — VP, Controller and CAO | Mar 29, 2022 | Tax withholding | 965 | $2.52 |
| Maletta Matthew JosephOfficer — EVP, CLO & Company Secretary | Mar 29, 2022 | Tax withholding | 8,472 | $2.52 |
| Bradley Mark T.Officer — EVP, Chief Financial Officer | Mar 29, 2022 | Tax withholding | 2,544 | $2.52 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Bankruptcy or receivershipApr 18, 2024
- Bankruptcy or receivership · Other material eventMar 25, 2024
- Results of operationsMar 6, 2024
- Entered a material agreement · Regulation FD disclosureJan 2, 2024
- Other material eventDec 29, 2023
- Regulation FD disclosureDec 26, 2023
- Other material eventNov 30, 2023
- Results of operations · Regulation FD disclosureNov 6, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.